- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05966220
Post Market Clinical Follow-up of Hip Surgery Using FH ORTHO Company Medical Devices. (HipFHOrtho)
Post Market Clinical Follow-up of Hip Surgery Using FH ORTHO Company Medical Devices (FH ORTHO Company Hip Observatory).
The objective of this observatory is to generate additional real life clinical data in accordance with local regulation (i.e. Post-Market Clinical Follow-up (PMCF) study, a study carried out following the European Conformity (CE) marking of a device and intended to answer specific questions relating to clinical safety or performance (i.e. residual risks) of a device when used in accordance with its approved labelling).
The difficulty of such an observatory is to be able to collect data on the different versions of the devices, on the different possible combinations of implants of an arthroplasty. The observatory must also be able to cover devices used in surgery to repair osteoarticular trauma.
The observatory will be based on the principle of a "dynamic" cohort during the inclusion period, i.e. with possible inclusions to replace the premature exits.
Technical solutions will be implemented to facilitate data collection from surgeons (electronic Case Report Form (eCRF) and from patients (Electronic Patient Reported Outcome (ePRO) on phone/tablet/computer).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Any patient undergoing or having undergone implantation of medical devices distributed by FH ORTHO Company for hip arthroplasty and traumatology, used in accordance with their approved Instruction For Use, in one of the centers participating in the Observatory.
- Patient is at least 18 years of age.
- Patient agreeing to participate after having been informed orally and in writing (with written consent if required locally).
- In some countries, such as France, the patient will have to be socially insured to be included in the study.
Exclusion Criteria:
- An infection, or latent infection.
- A mental or neuromuscular disorder that would create an unacceptable risk of prosthetic instability, failure of prosthetic fixation, or post-operative complications (except for the HIP&GO Double mobility cemented cup and, if applicable, the associated stems and heads when assembled together).
- Known Insufficient bone quality and/or bone stock.
- Known allergy to any component of the material listed on the product label.
- Metabolic diseases that could compromise bone regrowth.
- Metabolic and/or vascular treatment or disease that may compromise bone healing or consolidation.
- Drug dependency.
- Uncooperative patient unable to follow recommendations.
- Protected adult
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Total hip arthroplasty (THA) and Revision THA
Patients will be monitored for up to 15 years postoperatively.
|
This study is a real-life observatory designed to collect long-term clinical data on patients who have undergone hip joint replacement or repair following hip trauma. In this type of intervention, one or more medical devices distributed by FH ORTHO Company may be used by surgeons. |
Other: Traumatology: femoral neck Total hip arthroplasty or hemiarthroplasty
Patients will be monitored for up to 10 years postoperatively.
|
This study is a real-life observatory designed to collect long-term clinical data on patients who have undergone hip joint replacement or repair following hip trauma. In this type of intervention, one or more medical devices distributed by FH ORTHO Company may be used by surgeons. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Survival rate (revision) of the medical device over the long term (maximum 15 years).
Time Frame: maximum 15 years.
|
maximum 15 years.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2021-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Surgery
-
Medical University of GrazCompleted
-
Robert Jones and Agnes Hunt Orthopaedic and District...Not yet recruiting
-
Riphah International UniversityCompleted
-
Fondation Hôpital Saint-JosephCompletedHip Prosthetic Surgery | Knee Prosthetic SurgeryFrance
-
University of Wisconsin, MadisonEnrolling by invitation
-
Charite University, Berlin, GermanyEdwards LifesciencesUnknown
-
Sodertalje HospitalCompleted
-
Health Service Executive, IrelandCompletedHip Surgery Corrective
-
Northwell HealthWithdrawnOrthopaedic Surgery | Total Hip Arthroplasty | Hip Replacement | Hip ImplantUnited States
Clinical Trials on Hip surgery with FH Ortho devices
-
Aga Khan UniversityCompleted
-
Massachusetts General HospitalActive, not recruitingAcetabular Labrum Tear | Osteoarthritis, Hip | Physical Therapy | Femoro Acetabular Impingement | Hip ArthroscopyUnited States
-
Hadassah Medical OrganizationUnknownMotor Impairments | Orthopaedic Injuries | Neurological ConditionsIsrael